000 01455nam a2200385 a 4500
001 0000138882
005 20171002061548.0
006 m u
007 cr cn|||||||||
008 101008s2011 njuaf sb 001 0 eng d
010 _z 2010043285
020 _z9780470184745 (cloth)
020 _z9781118015377
020 _z9781118015360
020 _z9781118015353 (e-book)
035 _a(CaPaEBR)ebr10494542
035 _a(OCoLC)757827332
040 _aCaPaEBR
_cCaPaEBR
050 1 4 _aQR201.A37
_bH547 2011eb
082 0 4 _a616.97/9201
_222
245 0 0 _aHIV-1 integrase
_h[electronic resource] :
_bmechanism and inhibitor design /
_cedited by Nouri Neamati.
260 _aHoboken, N.J. :
_bWiley,
_cc2011.
300 _axiii, 506 p., [15] p. of plates :
_bill. (some col.).
490 0 _aWiley series on drug discovery and development
504 _aIncludes bibliographical references and index.
533 _aElectronic reproduction.
_bPalo Alto, Calif. :
_cebrary,
_d2011.
_nAvailable via World Wide Web.
_nAccess may be limited to ebrary affiliated libraries.
650 0 _aHIV (Viruses)
_xEnzymes.
650 0 _aHIV (Viruses)
_xEnzymes
_xInhibitors.
650 0 _aAntiviral agents.
655 7 _aElectronic books.
_2local
700 1 _aNeamati, Nouri.
710 2 _aebrary, Inc.
856 4 0 _uhttp://site.ebrary.com/lib/daystar/Doc?id=10494542
_zAn electronic book accessible through the World Wide Web; click to view
908 _a170314
942 0 0 _cEB
999 _c128031
_d128031